Funding the Future with Series A&B Investing
April 7, 2025 | 8:00 am – 10:00 am
Join us for “Funding the Future: Series A & B Venture Investing,” an in-depth conversation on the evolving landscape of life sciences venture funding. This session will explore key trends, investor perspectives, and the strategies companies can implement to successfully navigate Series A & B financing rounds. Whether you’re an entrepreneur, investor, or industry leader, gain valuable insights to position your company for growth and success in 2025 and beyond. Don’t miss this opportunity to connect with experts shaping the future of life sciences innovation.
We will bring together industry experts to discuss the latest trends, key considerations for venture readiness, and what it takes to raise a series A or B venture round.
This year, we’re thrilled to welcome Benjamin Heywood, General Partner, SkyRiver Ventures; Tim Krochuk, CFA, Management Board Member, Shepherd Kaplan Krochuk; Darshana Zaveri, Managing Partner, Catalyst Health Ventures; and Kristin King-Jankiewicz, Head of Group Management, Boston Harbor Angels. The discussion will be moderated by David Fogel, Managing Director, Swifton CFOs.
Gain valuable perspectives from these industry leaders as they share their predictions and strategies for the year ahead.
Following the panel, join us for a lively, moderated Q&A session, where your questions and insights will enrich the conversation.
We look forward to seeing you at this dynamic and thought-provoking event!
Panelists
MODERATOR
David Fogel, CPA, Managing Director
Swifton CFOs
David is Managing Director of Swifton CFOs LLC, an outsourced consulting firm that provides emerging businesses with strategic and cost-effective financial leadership. He is an active member of the screening and due diligence committees of Beacon Angels and Mass Medical Angels and has been an active presenter at Harvard Medical School, TechStars, Entreprise Forum, and others. David is an Adjunct Instructor of Finance at Northeastern University for the past six years, teaching Entrepreneurial Finance.
Benjamin Heywood, General Partner
SkyRiver Ventures
Benjamin serves as a General Partner at SkyRiver Ventures. SkyRiver Ventures is a leading venture capital firm focused on investing in early stage technologies between North America and Asia. As an entrepreneur in 2004, He co-founded PatientsLikeMe, an early social network for people with chronic illness.
Tim Krochuk, CFA, Owner, Management Board Member
Shepherd Kaplan Krochuk (SKK)
Tim is an owner and member of the Management Board of Shepherd Kaplan Krochuk. He is the Co-Head of Alternative Investments for the Firm’s Asset Management Division, with over 25 years of experience in investment research and management. He serves on the board of, or in an advisory capacity to, several private and public companies in the United States and Canada, including Windgap Medical Inc. and Etiometry Inc.
Darshana Zaveri, Founder and Managing Partner
Catalyst Health Ventures
Darshana is a Founder and Managing Partner of Catalyst Health Ventures (CHV). She is actively involved in all aspects of fund management, including investments and capital raising, and has led several investments in the medical device, women’s health, and diagnostics markets. She led CHV’s investments in Augmenix (acquired by Boston Scientific), nVision Medical (acquired by Boston Scientific), Maxwell Health (acquired by SunLife), Aria CV, PanTher Therapeutics, AtaCor Medical, Instylla, Avive and Rejoni.
Kristin King-Jankiewicz, Head of Group Management
Boston Harbor Angels
Kristin is an accomplished biotech executive, serial intrapreneur, investor, and startup advisor. Kristin is an active Angel Investor and serves as EIR with Yale Ventures, Mentor with Endless Frontiers Lab, and Board member of Boston ENET. Kristin has championed healthcare innovation within startups and Fortune 100 Global companies, recently as Chief Business Officer of FiteBac Technologies and Vice President of Corporate Development, M&A at Defibtech Nihon Kohden.
Sponsors
